Showing results (21-30 of 43) with videos related to
Sort By:
Pageof 5
Journal of Cardiovascular Pharmacology|May 2, 2022
De-escalation of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: An Updated Meta-analysis and Trial Sequential Analysis of 21 Studies and 38,741 PatientsMeng-Jin Hu, Jiang-Shan Tan, Xiao-Jin Gao, et al.BMC Cardiovascular Disorders|April 15, 2025
Complex versus non-complex percutaneous coronary intervention in patients with atrial fibrillation: a real-world studyYimeng Wang, Han Zhang, Jiang-Shan Tan, et al.British Journal of Pharmacology|December 9, 2025
The sodium-glucose co-transporter 2 inhibitor, empagliflozin, attenuates pulmonary vascular remodelling by inhibiting the phosphorylation of PDGF receptor-βTing-Ting Lyu, Jing-Yang Wang, Jiang-Shan Tan, et al.Bioscience Trends|February 7, 2024
Diabetes mellitus, glycemic traits, SGLT2 inhibition, and risk of pulmonary arterial hypertension: A Mendelian randomization studyJiang-Shan Tan, Yanmin Yang, Jingyang Wang, et al.Journal of Translational Medicine|October 7, 2023
Causal relationships of circulating amino acids with cardiovascular disease: a trans-ancestry Mendelian randomization analysisSong Hu, Zhennan Lin, Meng-Jin Hu, et al.Thrombosis and Haemostasis|February 22, 2023
The Causality between Diabetes and Venous Thromboembolism: A Bidirectional Two-Sample Mendelian Randomization StudySong Hu, Jiang-Shan Tan, Meng-Jin Hu, et al.Open Heart|November 28, 2025
Development and validation of a 10-year predictive model for cardiovascular and metabolic disease risk: insights from a large-scale health examination cohortDejie Wang, Jiang-Shan Tan, Ruihan Liu, et al.Frontiers in Cardiovascular Medicine|September 26, 2022
Safety of chronic high-dose calcium channel blockers exposure in children with pulmonary arterial hypertensionYan Wu, Fu-Hua Peng, Xin Gao, et al.Frontiers in Cellular and Infection Microbiology|July 14, 2022
Genetic Predisposition of Anti-Cytomegalovirus Immunoglobulin G Levels and the Risk of 9 Cardiovascular DiseasesJiang-Shan Tan, Jia-Meng Ren, Luyun Fan, et al.Frontiers in Cardiovascular Medicine|June 20, 2022
Clinical Outcomes Following Hemodynamic Parameter or Intravascular Imaging-Guided Percutaneous Coronary Intervention in the Era of Drug-Eluting Stents: An Updated Systematic Review and Bayesian Network Meta-Analysis of 28 Randomized Trials and 11,860 PatientsMeng-Jin Hu, Jiang-Shan Tan, Lu Yin, et al.Pageof 5